3-{2-[(S)-4-(3-Guanidino-propyl)-2,5-dioxo-imidazolidin-1-yl]-acetylamino}-2-[(naphthalene-2-carbonyl)-amino]-propionic acid anion

ID: ALA1160229

PubChem CID: 44296892

Max Phase: Preclinical

Molecular Formula: C23H27N7O6

Molecular Weight: 497.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@@H]1NC(=O)N(CC(=O)NCC(NC(=O)c2ccc3ccccc3c2)C(=O)O)C1=O

Standard InChI:  InChI=1S/C23H27N7O6/c24-22(25)26-9-3-6-16-20(33)30(23(36)29-16)12-18(31)27-11-17(21(34)35)28-19(32)15-8-7-13-4-1-2-5-14(13)10-15/h1-2,4-5,7-8,10,16-17H,3,6,9,11-12H2,(H,27,31)(H,28,32)(H,29,36)(H,34,35)(H4,24,25,26)/t16-,17?/m0/s1

Standard InChI Key:  NALFUKWGEKEECL-BHWOMJMDSA-N

Molfile:  

     RDKit          2D

 36 38  0  0  0  0  0  0  0  0999 V2000
    1.4125   -0.6000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1542   -1.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7417   -0.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3292   -1.3875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3875   -1.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9875   -0.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6042   -1.4875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750   -0.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1625   -0.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1917   -0.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4333   -0.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0000   -1.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8042   -0.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7875   -1.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6375   -2.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4333    0.0458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7375    0.7125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5917   -0.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2042   -1.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4000   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9417    0.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4000   -0.3167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5417    0.4250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8292   -2.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6375   -1.7042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7208   -1.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292   -2.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4500   -3.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1583   -1.1917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7083   -0.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1750   -1.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1083   -0.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8500   -3.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3250   -0.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7917   -2.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6292   -3.1625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  7  1  0
  6 19  1  0
  7  6  1  0
  8  3  1  0
  9  6  1  0
 10  1  1  0
 11 26  1  0
 12  5  1  0
 13 10  1  0
 14 12  1  0
 15  2  2  0
 16 11  2  0
 17  3  2  0
 18 13  1  0
 19 18  1  0
 20 14  2  0
 21  9  1  0
 22  5  2  0
 23  9  2  0
 24 12  2  0
 25 13  2  0
 26 32  1  0
 27 28  2  0
 28 24  1  0
 29 11  1  0
  8 30  1  1
 31 20  1  0
 32 34  1  0
 33 27  1  0
 34 30  1  0
 35 31  2  0
 36 33  2  0
  8  4  1  0
 20 27  1  0
 35 36  1  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 497.51Molecular Weight (Monoisotopic): 497.2023AlogP: -0.68#Rotatable Bonds: 11
Polar Surface Area: 206.81Molecular Species: ZWITTERIONHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.50CX Basic pKa: 12.17CX LogP: -2.76CX LogD: -2.76
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.09Np Likeness Score: -0.57

References

1. Peyman A, Wehner V, Knolle J, Stilz HU, Breipohl G, Scheunemann KH, Carniato D, Ruxer JM, Gourvest JF, Gadek TR, Bodary S..  (2000)  RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.,  10  (2): [PMID:10673106] [10.1016/s0960-894x(99)00661-7]

Source